PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 117 filers reported holding PULMONX CORP in Q3 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $121,439 | +839.5% | 11,756 | +1092.3% | 0.00% | – |
| Q2 2023 | $12,926 | +107616.7% | 986 | -7.6% | 0.00% | – |
| Q1 2023 | $12 | -92.9% | 1,067 | -94.7% | 0.00% | -100.0% |
| Q4 2022 | $170 | -99.6% | 20,207 | +787.1% | 0.01% | +600.0% |
| Q3 2022 | $38,000 | -50.6% | 2,278 | -56.6% | 0.00% | -50.0% |
| Q2 2022 | $77,000 | -68.6% | 5,252 | -46.9% | 0.00% | 0.0% |
| Q1 2022 | $245,000 | +245.1% | 9,891 | +346.3% | 0.00% | +100.0% |
| Q4 2021 | $71,000 | +108.8% | 2,216 | +140.6% | 0.00% | 0.0% |
| Q3 2021 | $34,000 | -84.8% | 921 | -81.9% | 0.00% | -83.3% |
| Q2 2021 | $224,000 | +119.6% | 5,075 | +127.1% | 0.01% | +200.0% |
| Q1 2021 | $102,000 | +500.0% | 2,235 | +827.4% | 0.00% | +100.0% |
| Q4 2020 | $17,000 | – | 241 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG-WTT Global Life Science Capital Partners GP Ltd | 60,204 | $886,000 | 3.13% |
| PURA VIDA INVESTMENTS, LLC | 1,327,065 | $19,534,000 | 1.13% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,465,901 | $51,018,000 | 1.05% |
| NEXT CENTURY GROWTH INVESTORS LLC | 453,098 | $6,669,000 | 0.87% |
| Novo Holdings A/S | 510,555 | $7,515,000 | 0.37% |
| Rock Springs Capital Management LP | 702,400 | $10,339,000 | 0.30% |
| RTW INVESTMENTS, LP | 691,255 | $10,175,000 | 0.26% |
| TimesSquare Capital Management, LLC | 1,214,204 | $17,873,000 | 0.25% |
| FORMULA GROWTH LTD | 54,951 | $809,000 | 0.22% |
| Champlain Investment Partners, LLC | 2,129,760 | $31,350,000 | 0.20% |